Illinois Cancer Specialists

Industry News

Cancer drug divide between England and Wales

Mar 06, 2014

Patients suffering from cancer in England are up to seven times more likely to be prescribed expensive cancer drugs than fellow sufferers in Wales, a new study assessing the impact of the Cancer Drugs Fund has revealed. Read More

Nano systems tested to determine which works best in killing cancer cells

Mar 06, 2014

New UC research to be presented this week tested four iron-oxide nanoparticle systems to see which, when heated, would likely work best as a tool for targeting cancer cells. In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells. Read More

New diagnostic, treatment approach for aggressive prostate cancer suggested by cholesterol-metabolism study

Mar 06, 2014

Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.Findings also suggest that a class of drugs previously developed to treat atherosclerosis might be repurposed for treatment of advanced prostate cancer. Read More

Investigational drug may increase survival for some patients with advanced melanoma

Mar 06, 2014

An experimental drug aimed at restoring the immune system's ability to spot and attack cancer halted cancer progression or shrank tumors in patients with advanced melanoma, according to a multisite, early-phase clinical trial at Johns Hopkins Kimmel Cancer Center and 11 other institutions. Read More

Surgery over watchful waiting better for younger prostate cancer patients

Mar 06, 2014

A new study in the New England Journal of Medicine finds that mortality rates are lower for younger men having surgery for prostate cancer, compared with those who follow watchful waiting.Prostate cancer is common among older men and rare in men under the age of 40. Read More

Imprint of chemotherapy linked to inflammation in breast cancer survivors

Mar 06, 2014

Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.Now researchers at the Winship Cancer Institute of Emory University have found clues that may explain how these symptoms can linger. Read More

Some cancers evade detection by silencing parts of immune system cells

Mar 06, 2014

Johns Hopkins researchers say they have identified a set of genes that appear to predict which tumors can evade detection by the body's immune system, a step that may enable them to eventually target only the patients most likely to respond best to a new class of treatment. Read More